Citation Impact
Citing Papers
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer
2016
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
2010 Standout
Regulated Expression of a Tumor-Associated Antigen Reveals Multiple Levels of T-Cell Tolerance in a Mouse Model of Lung Cancer
2008
The Tissue-Engineered Vascular Graft—Past, Present, and Future
2015 Standout
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
2018
Cancer/testis (CT) antigens: Potential targets for immunotherapy
2009
Establishing the Diagnosis of Lung Cancer
2013 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells
2012
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
Cancer drug resistance: an evolving paradigm
2013 Standout
Tumor immunoediting and immunosculpting pathways to cancer progression
2007
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
The immune contexture in cancer prognosis and treatment
2017 Standout
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer?
2013
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
2017
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
The tumor microenvironment and its role in promoting tumor growth
2008 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells
2013
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
B Lymphocytes and Cancer: A Love–Hate Relationship
2016
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
2022
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Correlation between the Size of the Solid Component on Thin-Section CT and the Invasive Component on Pathology in Small Lung Adenocarcinomas Manifesting as Ground-Glass Nodules
2013
Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists
2009 StandoutNobel
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017
2017 Standout
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
2010
Regulatory B cells in anti-tumor immunity
2015
Translational nanoparticle engineering for cancer vaccines
2017
The B-Side of Cancer Immunity: The Underrated Tune
2019
Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma
2011
Computational selection of antibody-drug conjugate targets for breast cancer
2015
Works of Tetsuya So being referenced
Association between lymphangiogenesis-/micrometastasis- and adhesion-related molecules in resected stage I NSCLC
2010
Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer
2009
Limited pulmonary resection for peripheral small-sized adenocarcinoma of the lung
2010
Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growth.
2006
Identification of a New Cancer/Germline Gene,KK-LC-1, Encoding an Antigen Recognized by Autologous CTL Induced on Human Lung Adenocarcinoma
2006
Simultaneous Cellular and Humoral Immune Response against Mutated p53 in a Patient with Lung Cancer
2004
Antitumor Effect of Antibody against a SEREX-Defined Antigen (UOEH-LC-1) on Lung Cancer Xenotransplanted into Severe Combined Immunodeficiency Mice
2007
Haplotype Loss of HLA Class I Antigen as an Escape Mechanism from Immune Attack in Lung Cancer
2005
Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer.
2006